JANA Life Sciences announces that it has been certified to ISO 13485:2016. Read More


Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s Disease. Read More


EmpiraMed Debuts the First Patient-Centered Clinic Data Capture System

The PMR Portal Reduces Clinic Burden Related to Clinical Trials. Read More


Court Square Group congratulates our client Geoff Green, Chief Executive Officer at Longeveron Inc. as he joins the board of BioFlorida. Read more


Adlib Receives Significant Growth Investment from Diversis Capital Partners. Read more


How EmpiraMed’s PRO Portal and PMR Portal work. See for yourself why so many companies are adopting this innovative technology.


Longeveron Announces First Patient Treated in Phase 2b Hypoplastic Left Heart Syndrome (HLHS) Clinical Study. Read more


In the race for critical vaccines, AI technology delivers an unfair advantage. Read the new e-book from our partner Adlib to know how. Read now


Court Square Group is proud to partner with LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization as they announce the launch of new longitudinal study in collaboration with the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) titled Understanding the lung cancer Patient ExperiEnce in the Real-world setting (Project PEER). Read more



Biohaven Pharmaceuticals lands Khloe Kardashian as influencer of new migraine drug

Click here to read the full story


DCL Webinar: SPL is Here to Stay in the USA
Date: Wed, Jun 3, 2020
Time: 1:00 PM - 2:00 PM EDT
Register


ITRadiant to host webinar: SAP Returns Solution for Pharmaceutical Companies
Date: Thursday April 16, 2020
Time: 12 PM EST
Register


Court Square Group congratulates our long-standing Audit Ready #Compliant Cloud (ARCC) customer EmpiraMed on being selected to collaborate with non-profit LungGevity Foundation’s new global study, Project PEER. Court Square Group is proud to provide secure validated solutions and regulatory compliant environments to help improve critical life science data management and lung cancer clinical trial outcomes. Read the announcement